Navigation Links
Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
Date:12/1/2009

ALBUQUERQUE, N.M., Dec. 1 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced the appointment of Scott Glenn as chairman of the company's board of directors and chief executive officer.

Prior to joining Exagen, Glenn was managing partner of Windamere Venture Partners and founder of a number of successful biomedical companies including Prometheus Laboratories, Santarus, Dexcom, Somaxon Pharmaceutical and Cadence Pharmaceuticals. In addition, he was a founder at Zogenix, NovaCardia (sold to Merck) and Proprius (sold to Cypress). Prior to Windamere Ventures, he was the president and CEO of Quidel Corporation and before that he held various management positions, including division general manager with Allergan Pharmaceuticals. He serves as a director and founder of Evoke Pharmaceuticals and Planet Biopharmaceuticals.

"I am impressed with Exagen's unique position and approach to managing the massive amounts of genetic information created in the past decade, developing it into superior molecular diagnostics for use in a large number of diseases," said Glenn. Coperna, Exagen's search engine, is differentiated from competing methodologies because it can quickly analyze a broad amount of genomic information and identify statistically significant marker sets without the need for lengthy laboratory testing processes. This results in dramatic "speed to discovery" advantages for Exagen.

About Exagen

Exagen is the emerging leader in laboratory-discovered and developed genomic tests specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. Using Coperna, the company's proprietary, algorithm-driven computational tool and search engine that runs on high-performance computational clusters, it combines the ability to process massive amounts of data contained in genomic datasets with intelligent, rapid search methods. Coperna's targeted and precise discovery model has no conventional equivalent in the molecular diagnostics industry as it can identify relevant marker sets with superior sensitivity and specificity relative to markers identified via traditional analytical methods. For more information, visit www.exagen.com.

SOURCE Exagen Diagnostics, Inc.


'/>"/>
SOURCE Exagen Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Ancestry.com DNA Testing Reveals Roots Authors Scottish Ancestry
2. Scottsdale Facility to Be First in U.S. to Showcase True REST Technology
3. Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine
4. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
5. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
6. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
7. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
8. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
9. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
10. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
11. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016   AlloSource , ... cellular, bone, skin and soft-tissue allografts for use ... Business Process Manager, for being named to the ... National Quality Award by the Commerce Department,s National ... organization,s commitment to process excellence. The Baldrige Award ...
(Date:12/6/2016)... , Dec. 6, 2016  BTL Aesthetics ... proving that its BTL Vanquish ME device was ... energy delivery to the targeted tissue. The result: ... 53% higher, with BTL Vanquish ME versus BTL ... our physician network and their patients with the ...
(Date:12/6/2016)... 2016 With opioids commonly used for pain management for ... market that has led to nationwide fatalities. The synthetic ... stronger than heroin or morphine, resulting in likelihood of addiction, abuse ... , , ... clinical operations, Behavioral Health for HMC HealthWorks, explained the opioid drug ...
Breaking Medicine Technology:
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Sharon Kleyne, ... Global Climate Change and Your Health on Voice of America, declared on her radio ... call attention to the fact that when these bullies attack leaders in corporate America, ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Honolulu ... fully redesigned website, which launched October 17, 2016, features comprehensive information regarding a ... easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology treatments for ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers Delightful Holiday ... Up To 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 , ... Delightful Deals on Botox® and Juvederm® just in time for the holiday party ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... in Dallas, Texas, is condemning "scam operations" carried out by unethical locksmith companies ... these scam operations to a halt. According to Texas Premier Locksmith, these fraudulent ...
Breaking Medicine News(10 mins):